Enhancing the Therapeutic Effect Against Ovarian Cancer Through a Combination of Viral Oncolysis and Antigen-specific Immunotherapy
Open Access
- 1 April 2010
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 18 (4), 692-699
- https://doi.org/10.1038/mt.2009.318
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Treatment With Cyclooxygenase-2 Inhibitors Enables Repeated Administration of Vaccinia Virus for Control of Ovarian CancerMolecular Therapy, 2009
- Oncolytic viruses: a novel form of immunotherapyExpert Review of Anticancer Therapy, 2008
- Enhancing Poxvirus Oncolytic Effects through Increased Spread and Immune EvasionCancer Research, 2008
- Peptide Vaccine Given with a Toll-Like Receptor Agonist Is Effective for the Treatment and Prevention of Spontaneous Breast TumorsCancer Research, 2007
- Vaccinia virus preferentially infects and controls human and murine ovarian tumors in miceGene Therapy, 2006
- In vivo antigen delivery by aSalmonella typhimurium type III secretion system for therapeutic cancer vaccinesJCI Insight, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Oncolytic Viral Therapy for Cervical and Ovarian Cancer Cells by Sindbis Virus AR339 StrainClinical Cancer Research, 2005
- Using Sindbis Viral Vectors for Specific Detection and Suppression of Advanced Ovarian Cancer in Animal ModelsCancer Research, 2004
- Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same geneGene Therapy, 2001